Drug research

Enzalutamide

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Xtandi

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117	MacroGenics	Phase 2	Terminated	2024-07-04Actual
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyNCT07620574	Exelixis	Phase 3	Enrolling by invitation	2030-05-31Estimated
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117	Exelixis	Phase 3	Active not recruiting	2024-04-19Actual

MacroGenicsTerminatedPrimary completion: 2024-07-04 · Actual

Trial details

ExelixisEnrolling by invitationPrimary completion: 2030-05-31 · Estimated

Trial details

ExelixisActive not recruitingPrimary completion: 2024-04-19 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.